32P-post-labelling analysis of DNA adducts formed in the upper gastrointestinal tissue of mice fed bracken extract or bracken spores. by Povey, A. C. et al.
British Journal of Cancer (1996) 74, 1342-1348
© 1996 Stockton Press All rights reserved 0007-0920/96 $12.00
32P-post-labelling analysis of DNA adducts formed in the upper
gastrointestinal tissue of mice fed bracken extract or bracken spores
AC Povey" 2, D Potter2 and PJ O'Connor'
'Cancer Research Campaign, Department of Carcinogenesis, Paterson Institutefor Cancer Research, Manchester M20 9BX, UK;
2Menai Organics Limited, Bangor, Gwynedd, N Wales LL57 2UP, UK.
Summary Bracken toxicity to both domestic and laboratory animals is well established and tumours are
formed when rodents are treated with either bracken extracts or bracken spores. In this study we have
administered bracken spores and extract to mice in order to investigate whether such exposure leads to the
formation of DNA adducts. DNA, isolated from the upper gastrointestinal tract and liver, was digested to 3'-
nucleotides. Adducts were extracted with butanol, 32P-post-labelled, separated by thin layer chromatography
(TLC) and visualised and quantified using storage-phosphor technology. A cluster of adducts was clearly seen
in the DNA ofthe upper gastrointestinal tract, but not liver, 5 and 24 h after treatment with bracken extract or
bracken spores. These adducts were not observed in DNA extracted from vehicle-treated animals. Whereas,
after 5 h adduct levels in extract and spore-treated animals were similar, after 24 h adduct levels in the extract-
treated animals had diminished by >75%, but levels in spore-treated animals remained similar to those found
after 5 h. This suggests that the DNA-reactive compounds were being released slowly from the spores, even
though the spores had been sonicated before administration. Adducts were also quantified after the addition of
an internal standard (deoxyinosine 3'-monophosphate) by comparing the amount of label incorporated into the
adducts with that found in a known amount ofthe internal standard. Adduct levels using this internal standard
approach were similar to those found by direct measurement of radioactivity incorporated into the adduct,
indicating that the labelling of adducts was quantitative. We have tried, unsuccessfully, to synthesise
ptaquiloside, the principal carcinogenic component present within bracken. However, similar patterns of
adducts were observed when two other compounds, (1-(4-chlorophenyl sulphonyl)-l-cyclopropane carbonitrile
and 3-cyclopropylindeno [1,2-c] pyrazol-4-(0-methyl)oxime), which both contain a cyclopropyl ring, were
administered to mice. The adducts detected in bracken-treated animals may, thus, have arisen from
ptaquiloside but, whether these adducts arise directly from the compounds and bracken spores/extract
themselves or via an indirect mechanism, remains to be determined. As bracken-induced DNA adducts are
detectable in rodent tissues by a 32P-post-labelling procedure commonly employed to investigate DNA damage
in human populations, it may prove possible to apply such approaches to determine human exposure.
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The toxicity of bracken and bracken extracts giving rise to
various disease syndromes of domestic animals, including
carcinomas of the bladder in cows, is well established (Evans,
1984). Bracken fern is also carcinogenic to laboratory animals
(Evans and Mason, 1965) and, since then, the feeding offresh
or dry bracken fern, or the administration of its aqueous and
alcohol extracts, has produced cancers at numerous tissue
sites in cows, rats, mice, hamsters, toads and quails, giving
rise to a variety of soft tissue malignancies, leukaemias and
osteosarcomas (Evans and Mason, 1965; Evans, 1984; IARC,
1986). Fresh bracken spores, too, are carcinogenic, producing
gastric tumours and leukaemias (Evans, 1987). The carcino-
genic principle(s) of bracken can be transmitted via milk, as
demonstrated when milk from bracken-fed cows was used to
supplement the diet of mice (Villalobos-Salazar et al., 1990).
In humans, bracken intake has been associated with
elevated rates of oesophageal cancer in Japan [2.1-fold in
men and 3.7-fold in women (Hirayama, 1979)] and
oesophageal and gastric cancer in Brazil (Marliere et al.,
1995). Increased gastric cancer rates have also been observed
in North Wales where childhood bracken exposure was
associated with an elevated relative risk of 2.3 among people
living in small farming communities (Galpin et al., 1990).
Similarly in Costa Rica, increased risks of 2.3-fold (men) and
6.3-fold (women) were associated with mountainous regions
where bracken grows prolifically, compared with those of the
low lands, which are essentially bracken free (Villalobos-
Salazar et al., 1989). In the UK, bracken consumption is
rarely practised and, with the overall reduction in the use of
bracken fern for animal bedding and the lapsed practice of
the domestic use of bracken as a bedding material [e.g. the
so-called Channel Island greenbed (Lenfestey, 1972/73)],
contact with bracken dusts is a vanishing problem.
However, in common with many regions of the world, the
advance of bracken cover [in the UK up by an average of 1%
per annum and locally up to 30% (Taylor, 1986)] may lead to
an increased exposure to bracken spores during the late
summer, particularly in those years when sporulation rates
may be very high.
Bracken contains a number of toxic compounds, of which
ptaquiloside is thought to be the principal carcinogenic
compound. Ptaquiloside administration alone causes tu-
mours in experimental animals (Hirono et al., 1987). At
physiological pH, ptaquiloside is converted to an unstable
dienone (with the liberation of D(+) glucose), containing a
highly reactive cyclopropyl group, which can react rapidly
with amino acids, nucleosides and nucleotides and DNA
(Ojika et al., 1987; 1989). Reactions were observed at the N3
and N7 atoms of purines, the exocyclic oxygen atom of
guanine and with the phosphate in DNA. Strand breaks also
arise from the spontaneous cleavage of adducts at the N3 of
adenine (principally), but also N7 of guanine (Kushida et
al., 1994). The spectrum of base damage and intrinsic
instability caused by ptaquiloside thus resembles that of the
classical alkylating agents (Saffhill et al., 1985) and the
formation of these adducts may result in the carcinogenic
action of ptaquiloside.
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To aid in the determination of whether bracken is a
hazard to human health (Smith and Seawright, 1995), we
have investigated whether exposure to bracken results in the
formation of DNA adducts, which could potentially be used
as a biomarker in epidemiological studies. We have, thus,
administered bracken extracts and bracken spores to mice
and examined DNA from the target tissues for the presence
of DNA adducts by 32P-post-labelling.
Materials and methods
T4 polynucleotide kinase (T4-PNK') and 32P-y-ATP (specific
activity 6000 Ci mmol-1) were both purchased from New
England Nuclear (Stevenage, UK). Micrococcal nuclease (MN)
and calf spleen phosphodiesterase (CSPDE) were obtained
from Worthington (Lorne Laboratories, Reading, UK).
Alkaline phosphatase was supplied by Sigma (Poole, UK).
Glass PEI-cellulose plates were purchased from Schleicher-
Schuell (Anderman andCo., Kingston-upon-Thames, UK) and
plastic PEI-cellulose plates from Macharey-Nagel (Alltech,
Carnforth, UK). Deoxyinosine 3'-monophosphate (dIp) was
prepared by enzymic digestion of poly deoxyinosine (Pharma-
cia, St. Albans, UK) and isolated by high-performance liquid
chromatography (HPLC) fractionation of the digest.
and Gunther, 1973) and dibromoethane following published
procedures (Takahasi et al., 1985). 3-Cyclopropylindeno [1,2-
c] pyrazol-4-(O-methyl)-oxime was prepared by a three-stage
synthesis as follows: 2-cyclopropylcarbonyl-1,3-indanedione
was prepared from dimethyl phthalate and methyl cyclopro-
pyl ketone (Kilgore et al., 1945). The resulting 2-
cyclopropylcarbonyl-1,3-indanedione was then reacted with
hydrazine hydrate in methanol to yield 3-cyclopropylindeno
[1,2-c]pyrazole-4-one (Lemke et al., 1982). This was then
reacted with 0-methyl hydroxylamine hydrochloride in
pyridine to yield 3-cyclopropylindeno [1,2-c] pyrazol-4-(O-
methyl)oxime. The structures of these compounds are given
in Figure 1.
Bracken extracts and spores
Bracken samples were collected at Benllech, Anglesey,
Gwynedd (UK) and extracts were prepared following the
method used for the extraction of sesquiterpenoids from
Hypolepis punctata (Hayashi et al., 1977). Briefly, 1.5 kg of
fresh cut bracken was homogenised, extracted in 4 1 water
and absorbed onto activated charcoal. The absorbed material
was eluted with methanol, vacuum dried and reconstituted in
water. The spores were collected by Dr J Digby at a site at
the University of York, UK.
Synthesis of compounds containing the cyclopropane ring
1-(4-chlorophenyl sulphonyl)-1-cyclopropane carbonitrile was










Figure 1 Structures of (a) 1-(4-chlorophenyl sulphonyl)-1-
cyclopropane carbonitrile; (b) 3-cyclopropylindeno [1,2-c] pyra-
zol-4-(O-methyl)oxime and (c) ptaquiloside.
Treatment of animals
Groups of six 8-week-old female BDF1 mice (C57B1 x DBA2;
25-30 g body weight maintained on normal laboratory diet)
were given, by gavage under light fluorothane anaesthesia,
either 0.25 ml of water as a control, 25 mg bracken spores
per mouse (0.25 ml of 100 mg ml-1 sonicate in saline) or
0.25 ml of an aqueous extract of bracken frond. The dose of
bracken extract was calculated to contain approximately
8 mg ptaquiloside based on a published bracken fern content
(Hirono, 1986). The compounds, 1-(4-chlorophenyl sulpho-
nyl)-1-cyclopropane carbonitrile and 3-cyclopropylindeno
[1,2-c] purazol-4-(O-methyl)oxime, were administered at a
dose of 375 mg kg-1 in corn oil, with a control group of
animals treated with corn oil. Animals were sacrificed at 5
and 24 h after treatment. Liver and the entire upper
gastrointestinal tract (stomach and small intestine) were
taken, the gut contents were removed and the tissue rinsed
in saline. Tissue samples from the animals in the same
treatment group were frozen at approximately 70°C and
pooled for DNA extraction.
DNA adduct analysis
DNA was isolated from the upper gastrointestinal tract and
liver by standard phenol-based techniques and 25 ,ug DNA
was digested to nucleotides using methods described
previously (Haque et al., 1994; Povey and Cooper 1995) in
10 mM Tris-HCl containing 5 mM calcium chloride (pH 7.4)
using MN (0.5 units jig-1 DNA) and CSPDE (0.4 m
units jug-1 DNA) overnight at 37°C in a total volume of
62.5 ,ul. Aliquots of this digest (between 4 and 16 ,ug) were
then extracted with butanol (Gupta, 1985), neutralised with
1 jMl of 0.5 M Tris-HCl (pH 9.5) and dried in vacuo. In some
experiments 2 pmol dIp was added to act as an internal
labelling standard.
The adducted nucleotides were 32P-post-labelled for 1 h at
37°C in 30 mM Tris-HCl (pH 9.5) containing 10 mM
magnesium chloride, 10 mM DTT, 1 mM spermidine, 2.9 jgM
ATP (total concentration) using 2.5 units T4 PNK and 40 ,uCi
32P-y-ATP in a total volume of 10 ,ul. To separate
adducted nucleotides, 5 ,ul of the labelling mix was
chromatographed on plastic-PEI cellulose plates using as
dimensions: Dl, 1.0 M sodium phosphate (pH 6.5); D3, 3.5 M
lithium formate, 8.5 M urea (pH 3.5); D4, 1.2 M lithium
chloride, 0.5 M Tris, 8.5M urea (pH 8) and D5, 1.7 M sodium
phosphate (pH 6.0). To ensure that the detected adducts ran
into the middle of the thin layer chromatography (TLC)Bracken-induced DNA damage $0 AC Povey et al
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sheet, each plate was run twice with D3 and D4. When the
internal standard was added, 1 pl aliquots of the labelling




(Schleicher-Schuell) using 1 M ammonium formate (pH 3.5)





Figure 2 Phosphorimages of DNA adducts detectable in the gastrointestinal tract ofmice following treatment with bracken extract
(a and b), bracken spores (c and d) or vehicle control (e and f) at 5h (a, c and e) and 24h (b, d and f). Levels ofadducts marked 1, 2
and 3 are quantified in Table I.
Table I Level of adducts induced by bracken extract and bracken spores present in gastrointestinal tissue DNA
Time Adduct level (nmolmol'dGuo)a
Sample (h) 2 3
Bracken extract 5 2.0+0.6 6.3 (9.5+1.2)c 3.9+0.6 (3.3+2.0)
24 <0.1 0.8+0.3 (<0.1) 0.9+1.3 (<0.1)
Bracken spores 5 1.1 +0.6 6.6+ 1.6 (10.9+ 3.6) 3.8± 1.6 (3.0+0.5)
24 1.5+±0.6 8.0+ 1.3 (7.0+0.5) 2.2+2.1 (4.9+±0.6)
Vehicle control 5 <0.1 0.1I0.2 (<0.1) 0.2±0.3 (<0.1)
24 <0.1 <0.1 <0.1
aResults are given as mean
+ s.d. (n =3). bThe TLC position ofadducts 1, 2 and 3 are shown in Figure2.cResults in brackets are for those
determined using an internal standard method for determining adduct levels.Bracken-induced DNA damage
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Quantitation ofnormal nucleotides
To determine normal levels of nucleotides released, 10 ug
aliquots of the same DNA digest were treated with alkaline
phosphatase to give nucleotides that were then quantified by
HPLC (Cooper et al., 1992).
Adduct quantitation
TLC plates were dried, wrapped in plastic wrap and exposed
to a phosphor screen (Molecular Dynamics, Sunnyvale, CA,
USA) for up to 48 h. Sample visualisation was carried out
using a Molecular Dynamics 425S phosphorimager at 176 gm
resolution and volume quantitation was carried out using
Imagequant software (Molecular Dynamics). Background
determination for each individual image was carried out by
calculating the average of all pixel values in the outline of the
object.
In the absence of an internal standard, adducts were
quantified by comparing the signal with that of known
amounts of32p spotted onto the same TLC plates and exposed
together on the same phosphor screen for up to 48 h. The
amounts of adducts detected were then quantified by
determining the (adduct signal / 32p signal) ratio and assuming
that the adduct was labelled quantitatively. When the internal
standard was added, it was found that the response of the
phosphor screens to the signal from the internal standard was
linear only for a relatively short period oftime (<5 h). It was
thus not possible to compare directly the signal from the
internal standard with that from the adduct over an extended
period (48 h). A standard curve, forwhich the phosphor screen
response was linear for up to 48 h, was then prepared by
diluting stock [32P]-y-ATP between 100 and 106 times. The same
standard curve was then exposed to each ID plate (containing
the internal standard) and each Randerath plate (containing
the adducts) for 2 and 48 h respectively. Hence, the total
amount of adduct present was equal to (adduct signal)/
(standard signal 48 h) x(standard signal 2 h)/pdIp sig-
nal) x 400 fmol (to account for differences in the amounts
spotted on the different plates). In the absence of chemically
synthesised adduct standards, we haveassumed that the adduct
was labelled at the same efficiency as the internal standard.
Adduct levels are expressed as nmol adducts detected per mol
ofdGuo released (as determined by HPLC).
Results
A cluster of adducts, not present in the vehicle control, was
clearly seen in the analyses of the butanol extracts from the
digests ofDNAfromtheuppergastrointestinaltract obtained 5
and 24 h after treatment with bracken extract (Figure 2).
Furthermore, a similar adduct pattern was observed in the
DNA ofthose animals treated with bracken spores. Although
there appeared to be a number ofminor DNA adducts, three
adducts (1-3; Figure 2a) were consistently observed and
therefore quantified (Table I). After 5 h, adduct levels in
extract- and spore-treated animals were similar (mean levels
ranging from 1.1 to 6.6 nmol mol-' dGuo) but, whereas after
24 h adduct levels in the extract-treated animals had
diminished by >75%, levels in spore-treated animals were
similar to those found after 5 h. This suggests that the DNA
reactive compound(s) was being released slowly from the
spores, even though the spores had been sonicated before
administration. Liver DNA from treated mice did not exhibit
the same pattern of adducts, but only adducts that were
detected in both control and treated animals (data not shown).
The levels of bracken-induced adducts were also quantified
after the addition of an internal standard (dIp) to account for
variations in labelling efficiency. Figure 3 clearly demon-
strates that pdlp could be separated simply by one-
dimensional chromatography from contaminating nucleo-
tides and residual ATP. We found that quantitative labelling
of dIp in the butanol extract could be obtained only when
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Figure 3 Phosphorimages of 32P-labelled samples run one
dimensionally with (a) or without (b) the internal standard (dIp)
present. Lane 1, dIp; lane 2, a water blank and lanes 3 -5,
butanol-extracted adducts arising from bracken. Positions of
[32P]-y-ATP, pdIp and pdNp are marked on the images.
samples of <4,g DNA were digested and extracted. With
increasing amounts of DNA, higher levels of residual
nucleotides resulted in suboptimal labelling of dIp. Results
for the quantitation of adduct levels using the internal
standard approach were similar to those found in the absence
of the dIp, indicating that quantitative labelling of the
adducts had occurred in both the presence and absence of the
standard. There appeared to be no differences in the variation
of results obtained.
As part of this work, we have prepared a number of
compounds on the route to a synthesis of ptaquiloside. This
synthesis has so far been unsuccessful owing to the instability
of the cyclopropane ring during the multistep synthesis.
However, treatment of mice with 1-(4-chlorophenyl sulpho-
nyl)-l-cyclopropane carbonitrile and 3-cyclopropylindeno
[1,2-c]pyrazol-4-(O-methyl)oxime resulted in the formation
of adducts that were detectable in the DNA of the upper
gastrointestinal tract (Figure 4). The adduct pattern was
similar to those seen with bracken spores and bracken
extract: preliminary experiments indicated that these adducts
co-chromatographed with those adducts derived from
bracken spores or extract using the same urea-based solvent
systems or when using ammoniumn hydroxide/isopropanol as
D4 (Beach and Gupta, 1992).
Discussion
In this study we have demonstrated that DNA adducts
arising from exposure to bracken extract or bracken sporesBracken-induced DNA damage
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can be detected in the upper gastrointestinal tract of mice by
32P-post-labelling. As ptaquiloside is thought to be the
principal carcinogenic component in bracken (Hirono et al.,
1987) and reacts directly with nucleotides in vitro (Ojika et
al., 1987), these DNA adducts, detected by 32P-post-labelling,
may result from the interaction of an unstable dienone,
formed by the breakdown of ptaquiloside, with DNA. Their
identity is as yet unknown, but as T4-PNK only phosphor-
ylates adducts with a bulky substituent at the N7 position of
guanine poorly (Koivisto and Hemminki, 1990), an adduct at
the 7-guanine position would probably not have been
detected. The N3 adenine and N7 guanine ptaquiloside
adducts identified previously (Kushida et al., 1994) sponta-
neously depurinate in vitro with t1/2 of 18 and 40 h
respectively. As more than 75% of the adduct levels present
at 5 h, in mice treated with bracken extract, had been
removed by 24 h, the adducts detected in this study were




Figure 4 Phosphorimages of DNA adducts detectable in the gastrointestinal tract of mice following treatment with 1-(4-
chlorophenyl sulphonyl)-l-cyclopropane carbonitrile (a and b) and 3-cyclopropylindeno [1,2-c] pyrazol-4-(O-methyl) oxime (c and d)
or vehicle control (e and f) at 5 h (a, c and e) and 24h (b, d and f).Bracken-induced DNA damage
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lesions are removed by active repair processes as is the case
with N3 and N7 methylguanine adducts (Saffhill et al., 1985).
In order to generate the appropriate marker compounds
and so to provide definitive proof that these adducts arise
from ptaquiloside, we have tried to synthesise ptaquiloside
itself, but this has proved difficult owing to the instability of
the cyclopropyl ring (Ojika et al., 1987). Two other
compounds containing a cyclopropyl ring, namely 1-(4-
chlorophenyl sulphonyl)-1-cyclopropane carbonitrile and 3-
cyclopropylindeno [1,2-c]pyrazol-4-(O-methyl)oxime, were
synthesized and, when administered to mice, formed DNA
adducts in gastrointestinal tissue. The pattern of these
adducts was similar to that obtained with bracken extract
and bracken spores and initial co-chromatography experi-
ments indicated that adducts arising from these three
compounds could not be resolved. These results suggest
that adducts formed in mice treated with bracken extract or
spores may have arisen from ptaquiloside, as this compound,
as well as 1-(4-chlorophenyl sulphonyl)-l-cyclopropane
carbonitrile and 3-cyclopropylindeno [1,2-c]pyrazol-4-(O-
methyl)oxime, contains a cyclopropyl ring. However,
whether these adducts are in fact derived from the
compounds and bracken spores/extract per se or arise via
another mechanism, e.g. increased formation of endogenous
adducts such as I compounds (Randerath et al., 1986),
remains to be determined. One possible approach to identify
these adducts would be to synthesise ptaquiloside-DNA
adducts chemically so as to determine whether these adducts
are substrates for T4-PNK and can be detected using our
assay and chromatographic conditions.
Bracken consumption is associated with increased cancer
risk in Japan (Hirayama, 1979) and Brazil (Marliere et al.,
1995). Within the UK, exposure is now almost certainly
confined to bracken spores at times when bracken is
sporulating. At a site near Caernarfon in North Wales
(UK), the bracken spore count in a bracken stand rose from
zero levels over the course of 4-5 days to counts of
>800 per 1 or >9600 per 1 h'- and then fell to low levels.
These values equate to approximately 480 000 spores per
hour in the respiratory tidal flow volume. For comparison,
when air was sampled in a control, non-bracken area, the
count remained low (Heyworth et al., unpublished data;
Povey et al., 1995). As part of these exploratory studies, it
was also shown that walking for 15 min in a stand of
sporulating bracken while wearing a face mask, resulted in
deposition on the surface of the filter at the rate of
approximately 11 mg of spores h-'. As we have demon-
strated that DNA reactive compounds can be released from
spores, inhalation of bracken spores may thus provide a
significant route of exposure.
In this study, we have also used a modified version of the
assay (Shields et al., 1993) in which an internal standard is
added to the isolated DNA adducts in order to minimise
variations in labelling efficiency and have found that bracken-
induced adduct levels were similar whether or not an internal
standard was added (Table I). This is in contrast to previous
results in which it was reported that the addition of an
internal standard reduced the sensitivity of the assay to detect
polycyclic aromatic hydrocarbon adducts (Shields et al.,
1993). This suggests that the bracken-induced adducts are
labelled quantitatively in both procedures: the absolute
amount of adducts detected, however, remains to be
determined, as adduct losses may occur during the DNA
extraction, digestion and butanol extraction steps. Rather
than measuring the amount of internal standard directly as
described previously (on the PEI-cellulose plate before
removal of the excess [32P]-y-ATP; Shields et al., 1993), we
have found it simpler to chromatograph a separate aliquot
which enables the identification of both [32P]-y-ATP and the
internal standard [32P]pdIp (see Figure 3). Although the
actual procedure for quantitation is more complex than the
direct measurement of radioactivity incorporated, potentially
this approach can allow for variations in labelling efficiency.
As we add a known amount of an internal standard into the
labelling reaction, we can also directly determine whether the
labelling reaction had, in fact, occurred to the extent
expected. For example, although we have found that we
can detect adducts after extraction of digests of > 10 jig
DNA, the reproducibility of adduct.quantitation was poor
owing to increased levels of contaminating normal nucleo-
tides that had been coextracted. Under these conditions,
labelling of the internal standard was also reduced. This was
not a problem, however, with DNA digests containing <4 jug
DNA. These observations suggest that addition of an internal
standard may aid in increasing the reliability and reprodu-
cibility in adduct measurement, even for aromatic adducts.
In summary, we have now shown for the first time that
DNA adducts can be detected in rodents treated with either
bracken extract or bracken spores using a 32P-post-labelling
procedure commonly employed to investigate DNA damage
in human populations. As ptaquiloside is a known DNA-
damaging agent and is the principal carcinogenic component
in bracken, these adducts may arise from the interaction of
ptaquiloside with DNA. However, a comparable adduct
pattern was observed using two other compounds, whose
structures were only similar to ptaquiloside, in that they
contained a cyclopropyl ring, suggesting that these com-
pounds and bracken spores/extract may have induced the
formation of adducts by an indirect mechanism. As humans
are exposed to a large number of potential carcinogens,
further work will be necessary to develop methods that are
specific for the isolation of bracken-induced DNA adducts,
e.g. immunocolumns (Cooper et al., 1992), before human
exposure can be definitively demonstrated and accurately
quantified.
Abbreviations
MN, micrococcal nuclease; CSPDE, calf spleen phosphodiesterase;
dIp, deoxyinosine 3'-monophosphate; pdlp, deoxyinosine 3',5'-
bisphosphate; pdNp, 3',5'-bisphosphates of normal nucleosides;
T4-PNK, T4-polynucleotide kinase.
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